Antheia logo

Antheia Funding & Investors

Menlo Park, CA

Antheia is unlocking the medicinal power of nature. Its synthetic biology platform surpasses the limits of conventional drug discovery and manufacturing through a novel approach to whole cell engineering reconstructing complex molecules in yeast to bring to market next generation plant inspired medicines.

antheia.bio

Total Amount Raised: $164,101,696

Antheia Funding Rounds

  • Grant

    $12,000,000

    Grant Investors

    U.S. Department of Health and Human Services (HHS)
  • Grant

    $11,000,000

    Grant Investors

    BioMaP-Consortium
  • Series Unknown

    $6,000,000

    Series Unknown Investors

    IQT (In-Q-Tel)
    Echo Investment Capital
    Viking Global Investors
  • Debt Financing

    $40,000,000

    Debt Financing Investors

    First Citizens Bank
    Oxford Finance
  • Series B

    $73,000,000

    Series B Investors

    Viking Global Investors
    Sherpalo Ventures
    Hillspire
    Irregular Expressions
  • Series A

    $9,167,750

  • Grant

    $1,233,952

    Grant Investors

    National Science Foundation (NSF)
  • Series A

    $9,500,000

  • Grant

    $225,000

    Grant Investors

    National Science Foundation (NSF)
  • Seed

    $1,974,997

Funding info provided by Diffbot.